Show Summary Details
- Dedication
- Contributors
- Preface
- 1 A National Institute of Mental Health Perspective on Geriatric Mood Disorder Research
- 2 Research Priorities in Late-Life Mood Disorders
- 3 Epidemiology of Late-Life Mood Disorders
- 4 Public Health Burden of Late-Life Mood Disorders
- 5 Late-Onset Mood Disorders
- 6the diagnosis and treatment of unipolar depression in late life
- 7 Bipolar Disorder
- 8 Non-Major Depression
- 9 Anxious Depression
- 10 The Social Determinants of Depression in Older Adulthood
- 11 Depression in Dementia
- 12 The Challenge of Suicide Prevention in Later Life
- 13 Bereavement and Complicated Grief in Older Adults
- 14 Current Issues in Informal Caregiving Research
- 15 Post-Stroke Depression and Vascular Depression
- 16 Depression and Medical Illness in Late Life
- 17 Comorbid Neurological Illness
- 18 Substance Abuse Comorbidity
- 19 Comorbid Pain Disorders
- 20 Bidirectional Relationships Between Sleep, Insomnia, and Depression
- 21 Use of Adjunctive Therapy in Older Depressed Adults Who are Resistant to Antidepressant Treatment
- 22 Psychotherapy
- 23 Electroconvulsive Therapy and Neuromodulation in the Treatment of Late-Life Mood Disorders
- 24 Complementary and Alternative Medicine Approaches for Treatment and Prevention of Late-Life Mood Disorders
- 25 Prevention of Depression in Later Life
- 26 Depression Medication Treatment Adherence in Later Life
- 27 Depression in Long-Term Care
- 28 Late-Life Depression in the Primary Care Setting
- 29 Depression in Older Adults Receiving Hospice Care
- 30 Late-Life Mood Disorders and Home-Based Services and Interventions
- 31 Novel Platforms for Care Delivery
- 32 Structural Neuroimaging in Late-Life Mood Disorders
- 33 Molecular Imaging in Late-Life Depression
- 34 Functional Neuroimaging in Late-Life Mood Disorders
- 35 Cognitive Biomarkers in Depression
- 36 Neuropathological Markers in Late-Life Depression
- 37 Pharmacogenetics of Late-Life Depression
- 38 Pharmacokinetics and Pharmacodynamics in Late Life
- 39 Psychoneuroimmunology of Depressive Disorders
- 40 The Hpa Axis and Late-Life Depression
- 41 Clinical Prediction Models
- 42 Integration of Biological, Clinical, and Psychosocial Predictors of Treatment Response Variability in Late-Life Depression
- 43 Conclusion
- Index
(p. 129) Non-Major Depression
(p. 129)
Non-Major Depression
- Chapter:
- (p. 129) Non-Major Depression
- Author(s):
Ipsit V. Vahia
, Ganesh Kulkarni
, Thomas W. Meeks
, and Dilip V. Jeste
- DOI:
- 10.1093/med/9780199796816.003.0008
Non-major depression is an increasingly recognized clinical issue in older adults, as a growing body of evidence points to deleterious effects of this condition on emotional, cognitive and physical health. Yet, research in this area has been limited. This chapter aims to identify the primary clinical and research issues relevant to non-major depression, including a clarification of the nosology, epidemiology, clinical outcomes and comorbidity and treatment modalities.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Dedication
- Contributors
- Preface
- 1 A National Institute of Mental Health Perspective on Geriatric Mood Disorder Research
- 2 Research Priorities in Late-Life Mood Disorders
- 3 Epidemiology of Late-Life Mood Disorders
- 4 Public Health Burden of Late-Life Mood Disorders
- 5 Late-Onset Mood Disorders
- 6the diagnosis and treatment of unipolar depression in late life
- 7 Bipolar Disorder
- 8 Non-Major Depression
- 9 Anxious Depression
- 10 The Social Determinants of Depression in Older Adulthood
- 11 Depression in Dementia
- 12 The Challenge of Suicide Prevention in Later Life
- 13 Bereavement and Complicated Grief in Older Adults
- 14 Current Issues in Informal Caregiving Research
- 15 Post-Stroke Depression and Vascular Depression
- 16 Depression and Medical Illness in Late Life
- 17 Comorbid Neurological Illness
- 18 Substance Abuse Comorbidity
- 19 Comorbid Pain Disorders
- 20 Bidirectional Relationships Between Sleep, Insomnia, and Depression
- 21 Use of Adjunctive Therapy in Older Depressed Adults Who are Resistant to Antidepressant Treatment
- 22 Psychotherapy
- 23 Electroconvulsive Therapy and Neuromodulation in the Treatment of Late-Life Mood Disorders
- 24 Complementary and Alternative Medicine Approaches for Treatment and Prevention of Late-Life Mood Disorders
- 25 Prevention of Depression in Later Life
- 26 Depression Medication Treatment Adherence in Later Life
- 27 Depression in Long-Term Care
- 28 Late-Life Depression in the Primary Care Setting
- 29 Depression in Older Adults Receiving Hospice Care
- 30 Late-Life Mood Disorders and Home-Based Services and Interventions
- 31 Novel Platforms for Care Delivery
- 32 Structural Neuroimaging in Late-Life Mood Disorders
- 33 Molecular Imaging in Late-Life Depression
- 34 Functional Neuroimaging in Late-Life Mood Disorders
- 35 Cognitive Biomarkers in Depression
- 36 Neuropathological Markers in Late-Life Depression
- 37 Pharmacogenetics of Late-Life Depression
- 38 Pharmacokinetics and Pharmacodynamics in Late Life
- 39 Psychoneuroimmunology of Depressive Disorders
- 40 The Hpa Axis and Late-Life Depression
- 41 Clinical Prediction Models
- 42 Integration of Biological, Clinical, and Psychosocial Predictors of Treatment Response Variability in Late-Life Depression
- 43 Conclusion
- Index
